Title:
PYRAZOLOXAZOLE COMPOUND
Document Type and Number:
WIPO Patent Application WO/2011/043387
Kind Code:
A1
Abstract:
Disclosed is a compound represented by formula (I) or a salt thereof, which has an excellent CRF receptor antagonist effect.
(In the formula, R1 and R2 may be the same or different and each represents a hydrogen atom, a C1-6 alkyl group, a cyclic group (selected from among a C3-6 cycloalkyl group, a tetrahydropyranyl group, a dihydropyranyl group, a tetrahydrofuryl group, a dioxanyl group, a tetrahydrothienyl group, a dithianyl group and a hexahydrothiepinyl group), a C1-6 alkyl group that is substituted with a cyclic group (selected from among a C3-6 cycloalkyl group, a tetrahydropyranyl group, a dihydropyranyl group, a tetrahydrofuryl group, a dioxanyl group, a tetrahydrothienyl group, a dithianyl group and a hexahydrothiepinyl group), or the like; R3, R4 and R5 may be the same or different and each represents a hydrogen atom, a C1-6 alkyl group, a C3-6 cycloalkyl group, a C1-6 alkoxy group, a C1-6 alkoxy C1-6 alkyl group, a C3-6 cycloalkoxy C1-6 alkyl group or a halogen atom; R6 represents a hydrogen atom or a C1-6 alkyl group; and R7 represents a C1-6 alkyl group, a C1-6 alkoxy group or a C1-6 alkylthio group.)
Inventors:
SHIN KOGYOKU (GB)
TERAUCHI TARO (JP)
TAKAHASHI YOSHINORI (JP)
HASHIZUME MINAKO (JP)
TAKEDA KUNITOSHI (JP)
SHIKATA KODO (GB)
INOMATA AKIRA (JP)
TERAUCHI TARO (JP)
TAKAHASHI YOSHINORI (JP)
HASHIZUME MINAKO (JP)
TAKEDA KUNITOSHI (JP)
SHIKATA KODO (GB)
INOMATA AKIRA (JP)
Application Number:
PCT/JP2010/067564
Publication Date:
April 14, 2011
Filing Date:
October 06, 2010
Export Citation:
Assignee:
EISAI R&D MAN CO LTD (JP)
SHIN KOGYOKU (GB)
TERAUCHI TARO (JP)
TAKAHASHI YOSHINORI (JP)
HASHIZUME MINAKO (JP)
TAKEDA KUNITOSHI (JP)
SHIKATA KODO (GB)
INOMATA AKIRA (JP)
SHIN KOGYOKU (GB)
TERAUCHI TARO (JP)
TAKAHASHI YOSHINORI (JP)
HASHIZUME MINAKO (JP)
TAKEDA KUNITOSHI (JP)
SHIKATA KODO (GB)
INOMATA AKIRA (JP)
International Classes:
C07D491/048; A61K31/4162; A61P1/04; A61P9/00; A61P9/12; A61P25/00; A61P25/14; A61P25/18; A61P25/20; A61P25/22; A61P25/24; A61P25/28; A61P25/30; A61P25/32; A61P43/00
Domestic Patent References:
WO2002088121A1 | 2002-11-07 | |||
WO2004037822A1 | 2004-05-06 | |||
WO2009128383A1 | 2009-10-22 | |||
WO2010015628A1 | 2010-02-11 | |||
WO2002066439A1 | 2002-08-29 |
Foreign References:
JP2009510004A | 2009-03-12 | |||
JP2008517067A | 2008-05-22 | |||
JP2008503444A | 2008-02-07 | |||
JP2007515474A | 2007-06-14 | |||
JP2009234111A | 2009-10-15 | |||
USPP24974109P | 2009-10-08 | |||
US20040224974A1 | 2004-11-11 | |||
US5234818A | 1993-08-10 |
Other References:
DRUGS OF THE FUTURE, vol. 24, 1999, pages 1089 - 1098
JOURNAL OF PSYCHIATRIC RESEARCH, vol. 34, 2000, pages 171 - 181
EUROPEAN JOURNAL OF NEUROSCIENCE, vol. 13, 2001, pages 373 - 380
EUROPEAN JOURNAL OF PHARMACOLOGY, vol. 492, 2004, pages 195 - 201
GUT, vol. 53, 2004, pages 958 - 964
JOURNAL OF PSYCHIATRIC RESEARCH, vol. 36, 2002, pages 197 - 208
PSYCHOPHARMACOLOGY, vol. 150, 2000, pages 317 - 324
BRAIN RESEARCH, vol. 605, 1993, pages 25 - 32
PSYCHOPHARMACOLOGY, vol. 137, 1998, pages 184 - 190
JOURNAL OFNEUROCHEMISTRY, vol. 74, 2000, pages 199 - 208
BRAIN RESEARCH, vol. 893, 2001, pages 29 - 35
BRAIN RESEARCH, vol. 823, 1999, pages 221 - 225
GASTROENTEROLOGY, vol. 125, 2003, pages 654 - 659
BEHAVIOURAL BRAIN RESEARCH, vol. 138, 2003, pages 207 - 213
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, vol. 104, 2007, pages 10673 - 10678
JOURNAL OF NEUROCHEMISTRY, vol. 108, 2009, pages 165 - 175
JOURNAL OFNEUROSCIENCE, vol. 27, no. 24, 2007, pages 6552 - 6562
BRAIN RESEARCH, vol. 656, 1994, pages 405 - 408
BRAIN RESEARCH, vol. 744, 1997, pages 166 - 170
BRAIN RESEARCH, vol. 770, 1997, pages 89 - 95
BRAIN RESEARCH, vol. 881, 2000, pages 204 - 207
AUSTRALIAN JOURNAL OF CHEMISTRY, vol. 40, no. 11, 1987, pages 1841 - 50
BELZUNG C.; MISSLIN R; VOGEL E. ET AL.: "Behavioural effects of the benzodiazepine receptor partial agonist RO16-6028 in mice", PSYCHOPHARMACOLOGY, vol. 97, 1989, pages 388 - 391
JOURNAL OF PSYCHIATRIC RESEARCH, vol. 34, 2000, pages 171 - 181
EUROPEAN JOURNAL OF NEUROSCIENCE, vol. 13, 2001, pages 373 - 380
EUROPEAN JOURNAL OF PHARMACOLOGY, vol. 492, 2004, pages 195 - 201
GUT, vol. 53, 2004, pages 958 - 964
JOURNAL OF PSYCHIATRIC RESEARCH, vol. 36, 2002, pages 197 - 208
PSYCHOPHARMACOLOGY, vol. 150, 2000, pages 317 - 324
BRAIN RESEARCH, vol. 605, 1993, pages 25 - 32
PSYCHOPHARMACOLOGY, vol. 137, 1998, pages 184 - 190
JOURNAL OFNEUROCHEMISTRY, vol. 74, 2000, pages 199 - 208
BRAIN RESEARCH, vol. 893, 2001, pages 29 - 35
BRAIN RESEARCH, vol. 823, 1999, pages 221 - 225
GASTROENTEROLOGY, vol. 125, 2003, pages 654 - 659
BEHAVIOURAL BRAIN RESEARCH, vol. 138, 2003, pages 207 - 213
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, vol. 104, 2007, pages 10673 - 10678
JOURNAL OF NEUROCHEMISTRY, vol. 108, 2009, pages 165 - 175
JOURNAL OFNEUROSCIENCE, vol. 27, no. 24, 2007, pages 6552 - 6562
BRAIN RESEARCH, vol. 656, 1994, pages 405 - 408
BRAIN RESEARCH, vol. 744, 1997, pages 166 - 170
BRAIN RESEARCH, vol. 770, 1997, pages 89 - 95
BRAIN RESEARCH, vol. 881, 2000, pages 204 - 207
AUSTRALIAN JOURNAL OF CHEMISTRY, vol. 40, no. 11, 1987, pages 1841 - 50
BELZUNG C.; MISSLIN R; VOGEL E. ET AL.: "Behavioural effects of the benzodiazepine receptor partial agonist RO16-6028 in mice", PSYCHOPHARMACOLOGY, vol. 97, 1989, pages 388 - 391
Attorney, Agent or Firm:
HASEGAWA Yoshiki et al. (JP)
Yoshiki Hasegawa (JP)
Yoshiki Hasegawa (JP)
Download PDF: